Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
IMM CAREHUB - REDEFINING HEALTHY AGEING AND GERIATRIC REHABILITATION IN ASIA 2024-04-01 09:00
OFFICIAL LAUNCH OF THE NATIONAL UNIVERSITY SPINE INSTITUTE (NUSI): LEADING SPINE CARE INTO THE FUTURE 2024-03-30 11:00
CAIR-HK AI & Robotics Forum for Healthcare: Spotlight Interdisciplinary Integration of AI and Medicine 2024-03-29 23:00
Baird Medical Granted New Class III Certificate by China's NMPA for Ceramic Thyroid Ablation Needle 2024-03-29 21:37
Aohua receives Endoscopy Award at Healthcare Asia Medtech Awards 2024 2024-03-29 21:00
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights 2024-03-29 10:42
Jacobio Pharma Announces 2023 Annual Results 2024-03-29 08:50
Bridge Biotherapeutics Launches a Research Collaboration with Emory University School of Medicine to Explore Combination Therapy of BBT-877 for KRAS/P53 Mutant NSCLC Patients Resistant to Anti-PD-1 Blockade 2024-03-29 06:00
FullCare Medical starts medical garment production at Tatu City, Kenya 2024-03-28 23:25
Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future 2024-03-28 22:46
Broncus Medical (02216.HK) Announces Annual Results for 2023 2024-03-28 22:32
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 2024-03-28 21:00
Primech Holdings Limited Provides Financial Updates and Corporate Highlights For the Six Months Ended September 30, 2023 2024-03-28 20:30
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
1 8 9 10 11 12 890